1) human cervical carcinoma
人宫颈癌
1.
Tubeimoside I-induced ultrastructural changes of human cervical carcinoma HeLa cell line and the protective effect of cyclosporine A;
土贝母苷甲诱导的人宫颈癌HeLa细胞凋亡的超微结构变化及环孢菌素A的保护作用
3) human cervical cancer oncogene
人宫颈癌癌基因
1.
Expression and significance of human cervical cancer oncogene(HCCR) mRNA in hepatocellular carcinoma tissues;
肝癌组织中人宫颈癌癌基因mRNA的表达及意义
4) human uterine cervix cancer cell strains
人宫颈癌细胞株
1.
METHOD MTT method was adopted to observe the inhibiting effect of pentenol homologens on SGC-7901 human cancer cell strains,LoVo human colon adenocarcinoma cell strains and Hela human uterine cervix cancer cell strains.
方法采用MTT法,观察聚物烯醇同系物对SGC-7901人胃癌细胞株、LoVo人结肠腺癌细胞株、Hela人宫颈癌细胞株的抑制作用。
5) Hela cells
人宫颈癌Hela细胞
1.
Methods Cytotoxitity effect of artesunate and artesunate serum on human sarcoma Hela cells were determined by MTT assay in vitro.
方法采用四甲基二氮唑蓝(MTT)法观察青蒿琥酯及其含药血清对人宫颈癌Hela细胞的体外抑制作用。
6) human cervical carcinoma cell
人宫颈癌细胞
1.
Study on the radiosensitivity effect of E1A gene on human cervical carcinoma cell in vitro;
E1A基因对人宫颈癌细胞放射增敏的实验研究
2.
Effect of E1A gene on sensitivity of chemotherapeutics drug to human cervical carcinoma cell;
E1A基因对人宫颈癌细胞化疗药物敏感性的影响
3.
Effect of E1A gene on cell cycle of human cervical carcinoma cell;
PEI-Fe_3O_4纳米粒E1A基因对人宫颈癌细胞周期的影响
补充资料：宫颈复发癌
宫颈复发癌
多发生于晚期宫颈癌(包括局部晚期)治疗后，也有报告浸润性宫颈癌治疗后约有35%复发。复发性宫颈癌的治疗困难，预后差，是宫颈癌死亡最重要的原因。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条